Health Care Technology
Company Overview of 1928 diagnostics AB
1928 diagnostics AB develops a Web based diagnostic service for antibiotic resistant bacterial infections based on whole genome sequencing technology. The company offers an automated bio-informatic analysis of the bacteria’s genetic code by uploading the raw data files that are produced in hospitals and laboratories into a Web service. Its Web service then delivers full resistance profile based on the bacteria’s genome with treatment suggestions to the clinics and bacteriology laboratories. The company was founded in 2014 and is based in Gothenburg, Sweden.
Stena Center 1D
Gothenburg, 412 92
Founded in 2014
46 7 37 43 96 65
Key Executives for 1928 diagnostics AB
Similar Private Companies By Industry
|1928 diagnostics AB||Europe|
|Advanced MR Analytics AB||Europe|
|Arthro Therapeutics AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact 1928 diagnostics AB, please visit www.1928diagnostics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.